Because the expression of ERCC1 has been reported to be associated with platinum efficacy in NSCLC patients [31], we analyzed the relationship between expression levels of TS and ERCC1 and efficacy of pemetrexed plus platinum treatment. Here, TYMS is linked to non-small cell lung carcinoma.